Description
This webinar introduces NeuterReady, a breakthrough hormone diagnostic test designed to support veterinarians and pet owners in determining the optimal timing for neutering. Traditional “one-size-fits-all” approaches often overlook hormonal maturity, which can influence long-term health, behaviour, weight, joint development and immune function. The NeuterReady test measures functional steroid hormone activity, providing an accurate indication of sexual maturity from a single blood sample. Case examples demonstrate significant variability across breeds and ages, reinforcing that neutering decisions should be personalised rather than age based. The session highlights the emerging scientific focus on timing of neutering and the growing visibility of this topic in veterinary and mainstream media. Participants will learn how NeuterReady empowers evidence-based decision-making, improves discussions with owners, and supports best-practice recommendations. The webinar also introduces InsituGen’s broader suite of hormonal diagnostics that will support life-stage monitoring and reproductive health in the coming years
Learning Objectives
- Understand why neutering is no longer a “one-size-fits-all” decision and recognise how premature neutering may influence long-term health outcomes such as behaviour, musculoskeletal development, immune function and endocrine balance.
- Understand the importance of assessing hormonal maturity prior to neutering and how hormonal status can guide optimal timing of gonadectomy for different breeds and individual animals.
- Gain knowledge of how the NeuterReady diagnostic test works, including its functional hormone-based bioassay method, sample requirements and turnaround time, and how it differs from conventional hormone assays.
- Interpret NeuterReady results using real case examples and apply best-practice recommendations regarding timing of neutering based on maturity status rather than age alone.
- Enhance communication with pet owners by integrating evidence-based test results into discussions about neutering decisions, risk reduction, and personalised welfare-focused planning.
